Ning Li Selected Research

phenylalanyl- leucyl- phenylalanyl- glutaminyl- prolyl- glutaminyl- arginyl- phenylalaninamide

8/2020	Spinal administration of the multi-functional opioid/neuropeptide FF agonist BN-9 produced potent antinociception without development of tolerance and opioid-induced hyperalgesia.
1/2020	Central and peripheral modulation of gastrointestinal transit in mice by DN-9, a multifunctional opioid/NPFF receptor agonist.
10/2017	Peripheral and central sites of action for anti-allodynic activity induced by the bifunctional opioid/NPFF receptors agonist BN-9 in inflammatory pain model.
8/2012	Neuropeptide FF and related peptides attenuates warm-, but not cold-water swim stress-induced analgesia in mice.
2/2012	Effects of neuropeptide FF system on CB₁ and CB₂ receptors mediated antinociception in mice.
4/2011	Central administration of neuropeptide FF and related peptides attenuate systemic morphine analgesia in mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ning Li Research Topics

Disease

449	Neoplasms (Cancer) 11/2022 - 03/2002
135	Infections 12/2022 - 08/2003
129	Inflammation (Inflammations) 11/2022 - 03/2002
81	Hepatocellular Carcinoma (Hepatoma) 09/2022 - 04/2002
67	Breast Neoplasms (Breast Cancer) 07/2022 - 03/2002
52	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 06/2022 - 11/2004
51	Fibrosis (Cirrhosis) 10/2022 - 08/2005
51	Neoplasm Metastasis (Metastasis) 09/2022 - 07/2003
51	Lung Neoplasms (Lung Cancer) 01/2022 - 09/2004
46	Sepsis (Septicemia) 03/2022 - 02/2002
44	Hypoxia (Hypoxemia) 04/2022 - 04/2003
43	Body Weight (Weight, Body) 08/2022 - 05/2002
42	Carcinogenesis 01/2022 - 08/2002
40	Pain (Aches) 02/2022 - 07/2003
39	Stomach Neoplasms (Stomach Cancer) 02/2022 - 07/2005
35	Wounds and Injuries (Trauma) 02/2022 - 06/2002
34	Constipation 01/2022 - 03/2007
32	Pancreatitis 05/2020 - 09/2003
30	Carcinoma (Carcinomatosis) 05/2022 - 08/2004
30	Crohn Disease (Crohn's Disease) 01/2022 - 01/2008
27	Hemorrhage 10/2022 - 09/2003
24	Asthma (Bronchial Asthma) 03/2022 - 12/2003
23	Ischemia 09/2021 - 05/2005
22	Colorectal Neoplasms (Colorectal Cancer) 04/2022 - 01/2003
21	Stroke (Strokes) 12/2021 - 12/2009
20	Chronic Hepatitis B 12/2022 - 10/2005
20	Colitis 07/2021 - 02/2008
19	Disease Progression 01/2022 - 05/2014
19	Hypertension (High Blood Pressure) 01/2022 - 12/2005
18	Ischemic Stroke 03/2022 - 06/2012
18	Adenocarcinoma 01/2022 - 07/2003
18	Diarrhea 12/2021 - 07/2003
18	Cardiovascular Diseases (Cardiovascular Disease) 12/2021 - 12/2009
18	Necrosis 01/2021 - 10/2002
17	Rectal Neoplasms (Rectal Cancer) 04/2022 - 03/2006
17	Virus Diseases (Viral Diseases) 01/2022 - 01/2013
17	Chronic Obstructive Pulmonary Disease (COPD) 01/2022 - 03/2010
17	Heart Failure 11/2021 - 05/2009
16	Ovarian Neoplasms (Ovarian Cancer) 05/2022 - 03/2009
16	Adenocarcinoma of Lung 05/2022 - 09/2013
16	Liver Cirrhosis (Hepatic Cirrhosis) 01/2022 - 04/2007
16	Thyroid Neoplasms (Thyroid Cancer) 01/2022 - 08/2012
16	Esophageal Squamous Cell Carcinoma 10/2021 - 01/2008
16	Neuroinflammatory Diseases 01/2021 - 05/2012
16	Bullous Pemphigoid (Pemphigoid) 01/2018 - 04/2005
15	COVID-19 12/2022 - 01/2020

Drug/Important Bio-Agent (IBA)

212	Proteins (Proteins, Gene)FDA Link 08/2022 - 04/2002
113	Biomarkers (Surrogate Marker)IBA 05/2022 - 06/2004
92	Pharmaceutical PreparationsIBA 11/2022 - 01/2003
76	CytokinesIBA 09/2022 - 07/2003
75	MicroRNAs (MicroRNA)IBA 11/2022 - 01/2008
67	Therapeutic UsesIBA 05/2022 - 06/2002
56	Biological ProductsIBA 04/2022 - 04/2003
54	Messenger RNA (mRNA)IBA 12/2022 - 04/2002
36	EnzymesIBA 01/2022 - 07/2003
32	Glucose (Dextrose)FDA LinkGeneric 08/2022 - 04/2002
31	Interleukin-6 (Interleukin 6)IBA 11/2022 - 07/2003
31	DNA (Deoxyribonucleic Acid)IBA 04/2022 - 01/2002
31	AutoantibodiesIBA 01/2022 - 06/2003
29	LipopolysaccharidesIBA 10/2022 - 07/2004
29	Long Noncoding RNAIBA 02/2022 - 11/2014
26	LipidsIBA 12/2022 - 12/2006
25	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2022 - 07/2003
25	Transcription Factors (Transcription Factor)IBA 02/2022 - 12/2003
24	salicylhydroxamic acid (SHAM)IBA 01/2021 - 11/2006
23	InterferonsIBA 12/2022 - 01/2013
23	AntioxidantsIBA 08/2022 - 03/2002
23	CollagenIBA 01/2022 - 06/2006
23	Peptides (Polypeptides)IBA 01/2022 - 01/2007
23	AntigensIBA 02/2021 - 01/2004
22	Cisplatin (Platino)FDA LinkGeneric 03/2022 - 04/2003
21	LigandsIBA 05/2022 - 01/2006
21	RNA (Ribonucleic Acid)IBA 03/2022 - 10/2003
20	ErbB Receptors (EGF Receptor)IBA 01/2022 - 08/2005
20	VaccinesIBA 01/2022 - 01/2007
20	Immunoglobulin G (IgG)IBA 01/2022 - 12/2005
20	Antiviral Agents (Antivirals)IBA 07/2021 - 01/2013
19	Reactive Oxygen Species (Oxygen Radicals)IBA 05/2022 - 12/2003
19	Insulin (Novolin)FDA Link 01/2022 - 08/2003
19	NF-kappa B (NF-kB)IBA 12/2021 - 07/2003
18	Oxygen (Dioxygen)IBA 10/2022 - 01/2005
17	Small Interfering RNA (siRNA)IBA 07/2022 - 01/2006
17	Anti-Bacterial Agents (Antibiotics)IBA 02/2022 - 11/2006
17	Interleukin-10 (Interleukin 10)IBA 01/2021 - 11/2008
16	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 03/2022 - 02/2005
16	Particulate MatterIBA 03/2022 - 03/2002
16	InterleukinsIBA 01/2021 - 01/2007

Therapy/Procedure

236	Therapeutics 12/2022 - 05/2002
89	Drug Therapy (Chemotherapy) 05/2022 - 04/2003
48	Radiotherapy 04/2022 - 07/2003
35	Enteral Nutrition (Feeding, Tube) 12/2021 - 08/2003
29	Immunotherapy 09/2022 - 01/2007
25	Neoadjuvant Therapy 04/2022 - 04/2003
25	Electroacupuncture 01/2022 - 03/2007
25	Length of Stay 01/2022 - 01/2004
24	Aftercare (After-Treatment) 01/2021 - 07/2003
24	Fecal Microbiota Transplantation 01/2021 - 11/2014
19	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2022 - 05/2012
17	Operative Surgical Procedures 09/2021 - 03/2007
15	Laparotomy 01/2022 - 01/2004